How Glaukos Corporation stacks up

GKOS · against 136 other Healthcare companies of similar size

Valuation

8/ 100

Near the bottom of its peers.

Ranked #117 of 137 · scores higher than 0% of peers

Bars: peers in each 10-point band of the valuation score

21 peers with a valuation score of 0–9, including GKOS · Click a bar to see the companies

Why valuation scores 8?

Weighted metrics compared with all Healthcare companies.

Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.

Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -0.3% vs peer median 4.0%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -1.4% vs peer median 1.5%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.1% vs peer median 0.0%

Metric by metric

Position: dot = GKOS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	GKOS	Peer median	Better than	Weight
Earnings yieldHigher is better · 135 reported	-1.4%	2.7%	17%	30%
EBITDA yieldHigher is better · 138 reported	-0.3%	4.8%	16%	50%
Free cash flow yieldHigher is better · 87 reported	-0.2%	2.9%	24%	20%
Book yieldHigher is better · 135 reported	5.0%	20.5%	10%	Context only

Ranking by valuation score

Top 5 and the companies ranked around GKOS

Rank	Company	Market cap	Valuation	Overall
1	CSPC Pharmaceutical Group Limited1093.HK · Hong Kong	89.5B HKD (≈$11.5B)	98	67
2	Universal Health Services, Inc.UHS · US-listed	10.4B USD	96	64
3	Zhejiang NHU Company Ltd.002001.SZ · China	80.2B CNY (≈$11.2B)	95	76
3	Tenet Healthcare CorporationTHC · US-listed	21.5B USD	95	60
5	Fresenius Medical Care AGFMS · US-listed	11.6B USD	94	58
⋯
117	BioNTech SEBNTX · US-listed	21.8B USD	8	32
117	Crinetics Pharmaceuticals IncCRNX · US-listed	9.0B USD	8	51
117	Cytokinetics, IncorporatedCYTK · US-listed	8.7B USD	8	26
117	Guardant Health, Inc.GH · US-listed	23.5B USD	8	27
117	Glaukos CorporationGKOS · US-listed	13.7B USD	8	45
117	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	8	31
117	Insmed IncorporatedINSM · US-listed	22.8B USD	8	38
117	Madrigal Pharmaceuticals, Inc.MDGL · US-listed	9.2B USD	8	39
117	Vaxcyte, Inc.PCVX · US-listed	9.0B USD	8	33

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…